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Abstract 
Nanostructured hydroxyapatite (HAP) was prepared by a wet precipitation method using 
Ca(NO3) and KH2PO4 as the main material and NH3 as the precipitator under ultrasonic 
irradiation. The Ca/P ratio was set at 1.67 and the pH maintained at a minimum of 9. The 
temperature conditions and ultrasound influences were investigated using X-ray diffraction 
(XRD), Field Emission Scanning Electron Microscopy (FESEM) and Fourier Transform 
Infrared Spectroscopy (FT-IR). The results showed that Nano-HAP can be obtained by this 
method and the particles were achieved to around 30nm. 
Keywords: nanohydroxyapatite, biocompatible, biodegradable, chemical synthesis, ultrasound 
irradiation.  
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Introduction 
Bone is a natural organic-inorganic ceramic composite consisting of collagen fibrils with 
embedded well-arrayed nano crystalline rod-like shaped inorganic material of 25-50 nm in 
length [1, 2]. Hydroxyapatite (HAP) is the main inorganic calcium phosphate mineral 
component of bone and teeth, with a general formula of Ca10(OH)2(PO4)6. The close chemical 
similarity of HAP to natural bone has led to extensive research efforts to use synthetic HAP as 
a bone substitute and/or replacement in therapeutic cases [3, 4].  
The main advantages of synthetic HAP are its biocompatibility, its slow biodegradability in 
situ, good osteoconductive and osteoinductive capabilities it offers [5-7]. Investigation by 
Taniguchi et al [8] showed that sintered HAP exhibited excellent biocompatibility with soft 
tissue such as skin, muscle and gums. Such capabilities have made HAP an ideal candidate for 
orthopaedic and dental implants or part thereof. Synthetic HAP has been used widely for the 
repair of hard tissues and its common uses are bone repair, bone augmentation as well as 
coating of implants or acting as fillers in bone or teeth [9-11]. However the low mechanical 
strength of normal HAP ceramics restricts its use mainly to conditions of low load bearing 
applications. In some cases, these deficiencies can be alleviated by combining HAP with other 
materials such as polymers and/or glass. Materials such as high density polyethylene (PE) and 
polypropylene can be used to improve loading capabilities of HAP [12, 13].  
The complex structure of HAP has the added advantage of providing a very good absorption 
matrix for other molecules. The absorbing properties of HAP have been exploited in the 
formation of HAP-antibiotic and HAP-drug composites for slow release in situ [14-16]. This 
has proved effective in the treatment of diseases such as osteomyelitis as it allows better 
recovery from the disease [17]. 
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Recent discoveries and further research in nanoscience and nanotechnology have reignited the 
need to investigate the formation of HAP in the nanosized range and define clearly the 
properties of HAP at that scale. This is essential in nanotechnology as the different forms of a 
material at the nanoscale can have marked differences in physicochemical properties [18-21]. 
On many other occasions, great improvements have been observed with the use of 
nanostructures made of HAP [22-25]. In a study of HAP particle size influence, in vivo on 
osteoblasts, it was found by Jui-Sheng Sun et al [22] that there was an inflammatory inhibitory 
effect on the osteoblast cell cultures by smaller particles (0.5 – 3.0 µm). For any meaningful 
developments for the therapeutic use of nanohydroxyapatite (nano-HAP) in the medical field, 
macroscopic amounts of regular nano-HAP structures are needed with well-defined chemical 
and physical properties. 
In the past several methods have been developed to synthesize HAP and calcium phosphate 
ceramics. These techniques include homogeneous precipitation [26, 27], sol-gel [28], plasma 
spray [29], hydrothermal [30] and ultrasonic spray freeze drying [31] methods. Of all the 
methods mentioned, the wet chemical method is the easiest process to prepare HAP as it is 
economical and easy to operate without the need for expensive specialised equipment. 
Moreover chemical method can be scaled up quite easily to meet high demands. However, the 
main difficulty of this method is the fine morphology and size control within a small parameter 
range. 
A Wet chemical method has been used to produce crystalline materials from solutions in the 
desired crystalline phases at elevated temperatures. Particle size and morphology of HAP 
generated by this process can be controlled by varying experimental conditions that regulate 
nucleation, aging process and growth kinetics of the particles. The main parameters to obtain 
mono phase HAP are the raw starting material, preparation temperature and pH value. Using 
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the wet chemical method, A.J.Kkhopade et.al [32] and G.Han et.al [33] observed HAP 
particles with plate like structure or morphology in contrast to the spherical-shaped HAP 
produced when using ultrasonic irradiation. 
The precipitation method is the most common wet chemical method of preparing calcium 
phosphate ceramic and this can be either by a homogeneous or inhomogeneous process [34]. 
Electronic properties of HAP are sensitive to several variables such as Ca/P ratios, defects, size 
of crystals, temperature and preparation procedures [35]. Several chemical routes have been 
applied to the manufacture of HAP with varied results. Although the benefits of low cost and 
simplicity of precipitation techniques have long provided a direct avenue for HAP synthesis, 
the deviation from normal HAP phase can be significant with these techniques [36]. In 
addition, different HAP phases can result from the influence of other molecules utilised in the 
HAP synthesis. This molecule template approach was used effectively by Wang et al. [37] to 
make nanorods of HAP. 
Guo and Xiao [38] studied properties of nanocrystalline hydroxyapatite produced from the 
hydrothermal process and observed that the particle size decreases with increasing 
temperature. Meissner et al [39], in their studies observed that the size and morphology of 
HAP can be controlled and are dependent on precipitation temperature and ultrasonic power. 
Cao-Li-Yun et al [40] prepared monophase nano-HAP material with the use of ultrasonic 
power in the range of 300 W. The research on hydroxyapatite particle characteristics by 
Laquerriere et al has also shown that the  HAP particle size decreases with increasing 
temperature [41]. 
Wet milling is an important application in sample preparation. The use of ultrasonic irradiation 
in wet milling is an efficient means for grinding, dispersing, and deagglomerating the sample 
particles. The sonochemical effect in liquids is predominately that of acoustic cavitations. 
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Some of the advantages of ultrasound in manufacturing superfine-size slurries include 
increased reaction speed and reaction output, and more efficient energy usage [42]. In previous 
chemical precipitation methods, several raw materials have been investigated with varied 
degrees of success for fine control of shape and size. In this paper we report a recently 
developed chemical route with the use of calcium nitrate and potassium hydrogen phosphate as 
the main raw materials. The necessary pH control was provided by the addition of NH4OH. 
This hydrothermal method was also assisted by ultrasonic irradiation followed by heat 
treatment to manufacture the nanosized HAP.  
 
Experiment 
Materials:  
The chemicals used in this work include Ca(NO3)2⋅4H2O (99% pure), KH2PO4 (99% pure) and 
Ammonia solution which were used as Ca2+, PO43-, and OH- sources respectively. These were 
supplied by CHEM-SUPPLY. The ultrasonic processor was an UP50H (50 W, 30 kHz) 
supplied by Hielscher Ultrasound Technology. 
Procedure:  
HAP was synthesised by adding a 2.5 ml ammonia aliquot to 40 ml of 0.32 M Ca(NO3)2⋅4H2O 
solution under ultrasound irradiation. The pH value was checked and maintained at 9 at all 
times. Whilst under ultrasound irradiation, 60 ml of 0.19 M KH2PO4 solution was slowly 
added dropwise. A white precipitate was formed and the mixture was continuously irradiated 
with ultrasound power ranging from 0 to 50W (30 kHz) of maximum amplitude for 1 hour. 
The Ca/P ratio was kept at 1.67.  The solution was filtered by centrifugation and after filtration 
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the white precipitate was proportioned into a number of samples. These samples were then 
transferred into ceramic boats and placed in an electric tube furnace for thermal treatment at 
temperatures varying from 100 °C - 400 °C for a fixed time period. The duration of heat 
treatment time for the white precipitate at temperature of 100 °C was 12 hours, while the 
duration of heat treatment time for the white precipitate at temperatures ranging from 200 °C - 
400 °C was 2 hours. The longer heat reaction time for the 100 °C samples was necessary so as 
to produce crystalline and harder samples as initial work indicated mixed crystalline and 
amorphous soft end product. A total of 12 samples were matched to the power of ultrasound 
irradiation and heat reaction temperature used (see Table 1). The general procedure is 
graphically shown as a flow chart in Figure 1. 
 
Characterisation:  
The obtained final products were grinded into fine powder and characterised using XRD, SEM 
and FT-IR spectroscopy. Powder XRD spectra were recorded, at room temperature, using a 
Siemens D500 series diffractometer. XRD data collection details were: Radiation - Cu K 
(λ=1.5406 Å); Generator settings - 40 kV and 30mA; Speed - 0.04° step size with acquisition 
time of 2.0 seconds; 2θ range - 20° to 60°; and flat plane geometry. The powder XRD spectra 
give identifications of the purity of the final products (HAP) and any other phases that may be 
present. The crystalline size of the synthesized HAP was calculated from the XRD pattern 
using the Debye-Scherrer equation and determined by analysing corresponding Field Emission 
Scanning Electron Microscopy (FESEM) images. 
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The macrostructural and morphological features of HAP powders were investigated using 
FESEM. All scanning electron micrographs were taken using the high resolution field 
emission Zeiss 1555 VP-FESEM at 3 kV, 30 µm apertures under 1×10-10 torr pressure. 
FT-IR spectroscopy was performed using the Bruker Optics IFS 66 series FT-IR spectrometer. 
FT-IR spectra were taken for HAP samples prepared from a mixture of approximately 2g of 
HAP powder with 5-10 gm of spectroscopic grade KBr pressed to disk shape at 12-15 kPa. All 
FT-IR spectra were recorded in the 400-4000 cm-1 region. 
Results & Discussions: 
The crystalline phases of all the 12 HAP samples were found to be consistent with phases 
incorporated in the ICDD (International Centre for Diffraction Data) databases. Figure 2a 
shows the XRD patterns of samples (S-I to S-IV) synthesized without the use of ultrasound 
irradiation. Figure 2b shows the XRD patterns of samples (S-1 to S-8) synthesized with the use 
of ultrasound irradiation. Both Figures 2a and 2b show the XRD patterns for the samples 
synthesized at different reaction temperatures as indicated in Table 1. The main (h k l) indices 
for HAP are: (0 0 2), (2 1 1), (1 1 2), (3 0 0), (1 3 0), (2 2 2), (2 1 3) and (0 0 4) and are 
included in Figures 2a and 2b.  
All of the XRD patterns of samples S-I to S-IV (no ultrasound) show peaks with significant 
intensity in the 2θ range 23.4° - 23.7°, 26.9° - 27.4° and a much lower intensity peak at 40.4° - 
40.9° consistent with the CaH2P2O7 phase (JCPDS No. 41-0487). The intensities of these peaks 
are reduced in the 400 °C treated sample but noticeable enough to conclude that an impurity 
phase exists in the predominately HAP material. The XRD patterns of samples S-1 to S-8 
(ultrasound irradiated) show much reduced intensities for the 2θ range 23.4° - 23.7° and is 
insignificant in the 400 °C reaction temperature samples (S-4 and S-8).  The XRD patterns of 
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samples S-1, S-2, S-5 and S-6 (100 °C and 200 °C reaction temperatures) show significant and 
even enhanced intensity peaks in the 2θ range 26.9° - 27.4°. The intensity ratios of these peaks 
compared with those in the 23.4° - 23.7°  range do not entirely match the CaH2P2O7 phase. 
Known calcium hydrogen phosphate phases, such as CaH4(PO3)2?H2O (JCPDS 46-0494), do 
not seem to be the impurity phase as this would alter the intensity ratio of the (002) and (211) 
indexed HAP peaks considerably. A greatly reduced CaH2P2O7 phase and possibly 
diammonium hydrogen phosphate, (NH4)2HPO4 (Acta Crystallographica B28 (1972) 2065-
2069) phase seems to be present in the predominately HAP phase in the samples made at     
100 °C and 200 °C reaction temperature. CaH2P2O7 is a member from the family of crystalline 
and amorphous calcium phosphate phases that are often formed during temperature processing 
of hydroxyapatite synthesis according to Yingchao et al [43].  
The XRD results indicate that ultrasound irradiation has affected the chemical interactions of 
the reacting species by possibly altering the rate of formation and chemical equilibrium of the 
calcium hydrogen phosphate phases. Another chemical species, probably a type of calcium 
hydrogen phosphate, has been formed albeit in insignificant amounts in the higher 400 °C 
reaction temperature treated samples but significant amounts in the 100 °C to 200 °C samples. 
The HAP diffraction peaks become broader with increasing temperature (see Figure 2).       
The (0 0 2) HAP peak becomes broader as the temperature increases and the intensity remains 
fairly constant.  Cao-Li-Yun et al [40] observed a decrease in the (0 0 2) HAP peak intensity 
and reasoned this was due to the change in the shape of the HAP particles (acicular versus 
spherical).  From our results we deduce that the (0 0 2) HAP peak indicates the particles shape 
is the same for all samples. This is borne out by the SEM results that clearly show spherical 
particle shapes. 
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The crystalline size, t(hkl), of the synthesized HAP were calculated from the XRD pattern 
according to the Debye-Scherrer equation [44-47]  
)(
)(
cos
.
hkl
hkl B
t

90 λ
=
          (1) 
where ‘’ is the wavelength of the monochromatic X-ray beam, B is the Full Width at Half 
Maximum (FWHM) of the peak at the maximum intensity, (hkl) is the peak diffraction angle 
and satisfies Bragg’s law for the (h k l) plane and t(hkl) is the crystallite size. 
The HAP average crystallite size using the (0 0 2) reflection peak from the XRD pattern was 
calculated using Scherrer’s equation. This was done so that the products could be compared 
with each other. The particle sizes, calculated from Equation (1), for samples S-1 to S-8 and   
S-I to S-IV are shown in table 2. The results show the particle size of the HAP crystallites 
decrease with increase in the reaction treatment temperature. Furthermore from Table 2 we can 
conclude that as the percentage of available ultrasonic power increases the particle size of the 
HAP crystallites decreases.  
The particle size is related to nucleation and growth pattern of the material and this is highly 
related to the degree of super saturation in the liquid phase.  With ultrasound presence there is 
creation of micro jets and shock wave impact due to the collapse of micro bubbles and these 
promote hot spots with very high cooling rates [48]. These effects promote chemical reactions 
and physical effects, thus ultrasound can be used for the synthesis of materials in liquid phase 
[49]. Raising the ultrasound power in our study by from 0, 25 to 50 W we could identify a 
decrease in particle size. The sonication power influences the level of cavitations in the liquid 
and with higher power ultrasound generating the larger number of cavitations events due to 
more transient cavitations bubbles being formed. It can be expected that as more nucleation 
sites are created the particles formed around these sites are smaller for the same original 
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reagent concentration. In addition, formed particles exposed to longer contact time with 
ultrasound is expected to show decreased level of agglomeration. FESEM results confirm 
decrease of level of agglomeration when ultrasound is used in the reaction process. 
 
In addition microscopy techniques such as FESEM were used to investigate the size and 
morphology of the HAP powders produced. Figures 3a – 3c are FESEM images from samples 
with treatment temperatures 300 °C and 400 °C and without ultrasound irradiation. These 
images show small spherical particles agglomerating onto larger particles. The average sizes of 
the smaller particles are included in Table 2.  Figures 3d – 3g are FESEM images from 
samples with treatment temperatures 300 °C and 400 °C and with ultrasound irradiation (50 
W). These images show small spherical particles with average sizes as tabled in Table 2. 
Spherical particle morphology is observed in all of the samples produced. These are similar to 
the particle morphologies reported elsewhere [50-55]. Details of the observed average particle 
size from FESEM images are tabulated in Table 2. The FESEM results compare favourably 
with the calculated grain size from the XRD spectra. 
Figure 4 shows typical FT-IR spectra of nano-HAP. The bands at 564, 601 cm-1 are from the 4 
vibrations of the O-P-O mode. The 961 cm-1 band resulted from the 1 P-O symmetric 
stretching vibrations. The two weak peaks at 725 cm-1 and 832 cm-1 are associated with the 
carbonate group which reveals the presence of carbonates in our samples. The very strong 
bands at 1032 cm-1 and 1092 cm-1 correspond to the PO43- functional group. The peak at 1384 
cm-1 corresponds to the CO2-3 functional group. The carbonate ion is likely to come from the 
reaction of HAP alkaline samples with atmospheric carbon dioxide as observed elsewhere [56-
58]. The weak peak at 1644 cm-1 corresponds to the CO2-3 group. The band at 3432 cm-1 
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corresponds to absorbed water while the weak peak at 3570 cm-1 corresponds to the vibrations 
of OH- ions in the HAP lattice. This indicates that the samples are of high quality. 
Conclusion: 
This study has shown that nano-HAP particles with a spherical morphology in the nano metre 
size range (approximately 30 nm ± 5%) can be synthesised using a hydrothermal chemical 
precipitation method incorporating low power sonic irradiation. The crystallinity and 
morphology of HAP depends on Ca/P ratio, ultrasonic irradiation and temperature. Ultrasonic 
power of 50 W and temperatures in the range of 400 °C is sufficient to produce the nano-HAP. 
This demonstrates an economic route to nano-HAP synthesis with a strong scale-up capability. 
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Captions: 
Table 1: Nano-HAP sample preparation conditions. 
Table 2: Nano-HAP particle sizes obtained from XRD and FESEM in terms of ultrasonic 
power and preparation temperature. 
  
 
ACCEPTED MANUSCRIPT 
 
17 of 17 
Figure 1: Experimental procedure for Nano-HAP preparation. 
Figure 2a: The XRD patterns for Nano-HAP (S-I to S-IV) prepared under the different 
experimental conditions listed in Table 1. 
Figure 2b: The XRD patterns for Nano-HAP (S1 to S8) prepared under the different 
experimental conditions listed in Table 1. 
Figure 3a – 3c: FESEM image of HAP powder without ultrasound (300 oC & 400 oC samples). 
Figure 3d – 3g: FESEM image of nanosized HAP with ultrasound (300 oC & 400 oC samples). 
Figure 4: A typical FT-IR spectrum of Nano-HAP. 
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Figure 2a
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Figure 3a
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Figure 3b
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Figure 3c
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Figure 3d
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Figure 3e
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Figure 3f
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Figure 3g
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Table 1
Sample Ultrasonic 
power (W)
Heat Treatment 
Temperature (oC)
Heat Treatment 
Duration (Hours)
pH
(minimum)
S-1 50 100 12 9.0
S-2 50 200 2 9.0
S-3 50 300 2 9.0
S-4 50 400 2 9.0
S-5 25 100 12 9.0
S-6 25 200 2 9.0
S-7 25 300 2 9.0
S-8 25 400 2 9.0
S-I 0 100 12 9.0
S-II 0 200 2 9.0
S-III 0 300 2 9.0
S-IV 0 400 2 9.0
  
 
ACCEPTED MANUSCRIPT 
 
Table 2
Particle Size (nm ± 5%) Temperature
Techniques Ultrasounds 
Power (W)
100 °C 200 °C 300 °C 400 °C
0 230 230 230 180
XRD 25 88 44 36 32 
50 58 35 30 25 
0 150 140 170 130
FE-SEM 25 72 60 43 36
50 48 40 28 26
